PTAB challenges

Proceedings overview

There is one AIA trial proceeding on file for US patent 8803836, which was terminated due to settlement. This means no claims were invalidated or sustained by the PTAB, leaving all claims of the patent untested by a final written decision. The patent's claims remain undiminished by PTAB action, which could make an IPR-based defense challenging without new grounds.

IPR2025-01246 — BOE Technology Group Co., Ltd. v. Takeshi Ookawara et al

• Type: Inter Partes Review
• Filed: 2025-07-10
• Status: Terminated-Settled. The proceeding was terminated before a final written decision was issued, indicating the parties reached a settlement.
• Judge panel: Information on the specific judge panel is not publicly available at this stage for a settled case without an institution decision or FWD.
• Petition grounds: The specific petition grounds, including claims challenged, prior art, and statutory basis (§ 102 / § 103 / § 112), are not publicly detailed for a case that settled before an institution decision was published.
• Institution decision: As the proceeding was filed on 2025-07-10 and subsequently settled, it likely settled before an institution decision was reached or published. The PTAB has a statutory deadline of 6 months from filing to issue an institution decision. The last modification date of 2026-04-07 suggests the settlement occurred before that date, potentially pre-dating any formal institution decision.
• Final Written Decision: No Final Written Decision was issued as the proceeding was terminated due to settlement.
• Settlement / termination: The proceeding was terminated as "Settlement" with a last modification date of 2026-04-07. The terms of the settlement are confidential.
• Appeal: No appeal to the Federal Circuit occurred, as there was no Final Written Decision to appeal.
• Defensive value: This proceeding indicates that BOE Technology Group Co., Ltd. found it strategically advantageous to settle with the patent owner rather than proceed to an institution decision or trial. For other defendants, this means the claims of US8803836 have not been tested or invalidated through an IPR, making the patent's validity in the face of similar prior art a potentially open question for new challengers.

Strategic summary

All 15 claims of US8803836 remain UNTESTED by a PTAB final written decision. Since IPR2025-01246 was terminated via settlement before reaching an institution decision or a Final Written Decision, none of the patent's claims were canceled or sustained by the PTAB. This leaves the patent in its original state regarding PTAB validity challenges.

The estoppel landscape for IPR2025-01246 is limited. As the proceeding settled before institution, it's unlikely that statutory estoppel under 35 U.S.C. § 315(e)(2) would apply to the petitioner (BOE Technology Group Co., Ltd.) or its privies for any grounds that "reasonably could have been raised." However, contractual estoppel from the settlement agreement would likely prevent BOE and its privies from challenging the patent again based on the same or related grounds. For other defendants, the full range of prior-art grounds remains available for potential challenges, assuming they are not in privity with BOE.

The filing of this IPR by BOE Technology Group Co., Ltd. indicates that the patent was considered a threat, leading to a challenge at the PTAB. The subsequent settlement, rather than a full PTAB trial, is a common pattern for patent owners seeking to monetize their intellectual property. The absence of an FWD means there are no PTAB-adjudicated validity rulings on record for this patent.

Recommended next steps

Since IPR2025-01246 was terminated by settlement, there are no active PTAB proceedings concerning US8803836, and no claims have been invalidated by the PTAB. If you are a defendant facing assertion of this patent:

• Evaluate prior art: Given the patent has not been subjected to a full IPR trial, a thorough prior art search for invalidity contentions is advisable. All claims remain legally viable and untested by the PTAB.
• Monitor for future PTAB activity: Keep an eye on the USPTO PTAB E2E system for any new petitions against US8803836 or related patents in the family. The absence of a PTAB validity determination means the patent owner may feel confident in asserting the claims.

No PTAB Final Written Decisions are available for this patent, and thus no dispositions to quote directly from a PTAB decision.

https://portal.unifiedpatents.com/ptab/case/IPR2025-01246